Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 16,574 | 22,258 | 17,993 | 22,934 | 17,817 |
| Cost of Goods | 4,589 | 8,606 | 6,300 | 6,731 | 4,779 |
| Gross Profit | 11,985 | 13,652 | 11,693 | 16,203 | 13,038 |
| Operating Expenses | 13,504 | 18,545 | 14,457 | 14,570 | 14,684 |
| Operating Income | -930 | -4,287 | -2,464 | 2,364 | -867 |
| Interest Expense | 994 | 3,509 | 0 | 0 | 1,283 |
| Other Income | 3,422 | 3,227 | -178 | -1,756 | -5,323 |
| Pre-tax Income | 1,498 | -4,569 | -2,642 | 608 | -7,473 |
| Income Tax | 405 | 695 | 245 | 828 | 0 |
| Net Income Continuous | 1,093 | -5,264 | -2,887 | -220 | -7,473 |
| Net Income Discontinuous | 381 | N/A | N/A | N/A | -647 |
| Net Income | $1,474 | $-4,617 | $-2,887 | $-220 | $-8,120 |
| EPS Basic Total Ops | 0.24 | -0.82 | -0.52 | -0.04 | -1.48 |
| EPS Basic Continuous Ops | 0.18 | -0.94 | -0.52 | -0.04 | -1.36 |
| EPS Basic Discontinuous Ops | 0.06 | N/A | N/A | N/A | -0.12 |
| EPS Diluted Total Ops | -0.15 | -0.82 | -0.52 | -0.04 | -1.48 |
| EPS Diluted Continuous Ops | -0.20 | -0.94 | -0.52 | -0.04 | -1.36 |
| EPS Diluted Discontinuous Ops | 0.04 | N/A | N/A | N/A | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.82 | -0.52 | -0.04 | -1.48 |
| EBITDA(a) | $524 | $-2,209 | $-384 | $5,084 | $1,124 |